市场调查报告书
商品编码
1355178
机械呼吸器市场 - 2018-2028 年全球产业规模、份额、趋势、机会与预测,按产品类型、介面、最终用户、地区、竞争细分Mechanical Ventilators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product Type, By Interface, By End User, By Region, Competition |
2022 年全球机械呼吸器市场估值为37 亿美元,预计在预测期内将实现强劲增长,到2028 年复合年增长率为6.1%。机械呼吸器是一种在手术或手术期间协助患者呼吸(通气)的设备。当他们因危重疾病而无法独立呼吸时。患者透过插入口腔并延伸到主气道或气管的中空管(人工气道)连接到呼吸器。机械通气的两种主要方法是正压通气(将空气强制输送到肺部)和负压通气(透过胸部运动将空气吸入肺部)。机械呼吸器通常用于治疗呼吸系统疾病、中风、慢性阻塞性肺病和其他疾病。机械通气是一种维持生命的技术,可帮助患有严重疾病的患者维持重要的呼吸功能。
老年人口的增加:老年人口的增长和慢性呼吸系统疾病的盛行率预计将推动对呼吸器的需求。对肺癌症状的认识提高以及医疗机构中患者数量的增加促进了呼吸机市场的显着增长。然而,重要的是要考虑到使用机械通气可能会带来某些风险,例如感染风险增加和潜在的肺部损伤。在评估机械呼吸器的市场成长潜力时应考虑这些因素。
市场概况 | |
---|---|
预测期 | 2018-2028 |
2022 年市场规模 | 37.4亿美元 |
2028 年市场规模 | 49.8亿美元 |
2023-2028 年复合年增长率 | 4.86% |
成长最快的细分市场 | 重症监护室/重症监护室 |
最大的市场 | 北美洲 |
慢性阻塞性肺病(COPD)盛行率激增:慢性阻塞性肺病和其他疾病(包括睡眠呼吸中止症、急性肺损伤和低氧血症)盛行率的上升是市场成长的主要驱动力。此外,早产数量的增加和老年人口的快速增长预计将进一步加速市场扩张。此外,吸烟率高,这是呼吸系统疾病的主要原因,将大大促进市场成长。据世界卫生组织(WHO)称,目前约90%的慢性阻塞性肺病死亡发生在低收入和中等收入国家。因此,由于此类疾病的盛行率不断上升、新产品的推出以及用于呼吸治疗的经济高效、便携式和用户友好的机械呼吸机的出现,全球市场预计将出现增长。例如,2020 年 8 月,Spicejet 推出了 Spiceoxy,一种便携式非侵入性通气设备。最终用户的意识不断提高预计将在预测期内推动需求。
与延长住院时间或医疗机构的长期照护相比,居家医疗保健(包括居家通风)可能更具成本效益。家庭护理还可以透过腾出医院床位来治疗更危急的病例,从而减轻医疗保健系统的负担。许多患者喜欢在自己舒适的家中接受医疗护理,包括呼吸支持。家庭医疗保健提供了更大的自主权、更好的生活质量,并减少了医院获得性感染的机会。此外,家庭医疗保健的便利性和舒适性等优势加上成本优势也有望推动市场成长。此外,医疗基础设施的增加和可支配收入的增加将导致对家庭医疗保健的高需求,从而成为市场的重要驱动力。此外,患者对呼吸系统疾病的认识不断提高也缓衝了预测期内市场的成长。
技术进步,例如气道正压 (PAP) 设备领域的快速创新、增强的便携性以及运输和便携式设备电池寿命的延长,是促进机械呼吸机使用的关键驱动力。 2020 年 4 月,InnAccel Technologies 宣布开发出一种非侵入性通气系统,专为 ICU 治疗 COVID-19 患者而设计。该系统在印度设计和製造,可满足低氧血症恶化患者的需求。此外,该系统的多功能性允许在各种环境和临床场景中应用,而无需持续供电或训练有素的呼吸治疗师。呼吸器技术进步的出现,加上重症监护病床(ICU)数量的增加,将有助于市场的成长。此外,预计非侵入性呼吸机的日益普及将推动机械呼吸机的需求。非侵入性通气采用各种接口,并不断发展以优先考虑患者的舒适度和有效性。近几十年来,透过鼻腔或面罩输送的非侵入性通气在支持慢性和急性通气衰竭方面已获得认可。
营运医院涉及大量固定成本,例如建筑维护、公用设施和设备采购。由于农村地区的患者数量较少,这些固定成本成为医疗机构预算的更大负担。与较大的城市医院相比,农村医院获得资金和财务资源的机会往往有限。他们可能很难投资机械呼吸器等昂贵的医疗设备,这可能会影响患者的照护能力。小型医疗机构面临的预算限制预计也会限制机械呼吸器的采用。农村和郊区医院努力为患者提供最高品质的护理,同时克服地理位置偏远、劳动力有限、规模小和财政资源有限带来的挑战。乡村医院的患者数量较少,使得这些组织在管理与医院运作相关的大量固定成本方面面临挑战。因此,他们特别容易受到保单和市场变化以及医疗保险和医疗补助付款减少的影响。
呼吸器相关性肺炎是机械通气患者常见的併发症。当细菌通过呼吸机管进入肺部并导致感染时,就会发生这种情况。 VAP 会延长住院时间并增加发病和死亡的风险。长时间使用呼吸器可能会导致呼吸器依赖,患者变得依赖机器呼吸且难以脱离呼吸器。与机械呼吸器的使用相关的潜在风险可能会阻碍该行业的成长。透过人工气道引入细菌会带来感染风险,而肺部微小气囊的反覆打开和关闭可能会导致肺部损伤。因此,预计这些设备的使用将在预测期内给呼吸机市场带来挑战。
与侵入性机械通气相比,非侵入性通气併发症的风险较低。插管是一种侵入性操作,可能导致呼吸器相关性肺炎、气管损伤和呼吸器相关肺损伤等併发症。在某些情况下,NIV 可用于呼吸系统疾病的门诊管理,为患者提供在家中或非急诊环境中接受治疗的灵活性。非侵入性通气可以作为病人摆脱有创机械通气的桥樑。它允许逐渐减少呼吸机支持,帮助患者恢復独立呼吸。人们越来越有兴趣开发非侵入性通气方案,无需插管即可提供有效的呼吸支持。这可以降低与有创机械通气相关的併发症的风险。
远端监控使医疗保健专业人员能够存取患者通气参数的即时资料,例如潮气量、呼吸频率、气道压力和氧气水平。这种连续的资料流提供了有关患者呼吸状态的宝贵见解,有助于及时做出决策。持续的远端监控使医疗保健提供者能够及时发现患者病情的细微变化。资料的突然波动或趋势可以触发警报,从而可以进行早期干预并防止潜在的併发症。透过远端监控,医疗保健专业人员可以最大程度地减少与患者和呼吸机的直接接触,从而降低潜在的医疗相关感染的风险,特别是在传染病爆发期间。具有远端监控功能的呼吸机可以为医疗保健专业人员提供连续的资料流,有助于对机械通气患者进行早期干预和更好的管理。
根据该产品,预计重症监护室市场在整个预测期内将大幅成长。这种增长可归因于多种因素,例如呼吸器在急性呼吸衰竭、肺功能受损或任何呼吸相关併发症中提供的临床益处。这些机械呼吸器广泛用于确保适当的通风并为医疗机构提供支援。先进的监控和视觉化决策支援是这些机械呼吸器的关键驱动因素,预计将对预测期内机械呼吸器的市场份额产生积极影响。
从最终用户细分来看,医院和诊所细分市场一直是市场的主导力量。训练有素的医疗保健提供者的增加有助于呼吸机的有效操作和使用,从而提高医院的生产力并专注于为客户提供优质的护理服务。这些因素是市场成长的关键驱动力,并将在预测期内继续推动市场向前发展。该行业的领先企业正在扩大其连锁医院,以提高诊断能力并提供有效的治疗。这些医院也投资基础设施,以提供全面的服务来对抗呼吸道疾病。这些发展,加上客户对慢性呼吸道疾病医院治疗的日益偏好,促进了医疗机构领域的成长。总体而言,由于这些因素的融合以及医院提供先进技术和便捷的医疗服务的能力,市场有望成长。
北美地区在 2022 年占据市场主导地位,主要是由于慢性阻塞性肺病 (COPD) 和需要非侵入性通气的呼吸系统疾病的盛行率不断上升。该地区受益于完善的医疗保健基础设施以及美国新泽西州 Becton、Dickinson 和 Company (BD) 等主要参与者的存在,进一步推动了市场成长。此外,北美地区重症监护入院人数不断增加,急性无创通气等新型通气模式的出现,也促进了机械呼吸器市场的扩大。
此外,亚太地区预计在 2022 年至 2028 年的预测期内将呈现最高的年复合成长率(CAGR)。这种增长可归因于该地区哮喘和肺癌等呼吸系统疾病盛行率不断上升等因素。非侵入性通气和侵入性通气都属于所使用的通气模式。此外,冠状病毒疾病的日益普遍正在成为亚太地区机械呼吸机市场进步的催化剂。
全球机械呼吸器市场报告以及给定的市场资料,技术科学研究可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项:
The Global Mechanical Ventilators Market was valued at USD 3.7 billion in 2022 and is expected to experience robust growth in the forecast period with a CAGR of 6.1% through 2028. A mechanical ventilator is a device that assists patients in breathing (ventilation) during surgeries or when they are unable to breathe independently due to critical illness. Patients are connected to the ventilator through a hollow tube (artificial airway) inserted into their mouth and extending into their main airway or trachea. The two primary methods of mechanical ventilation are positive pressure ventilation, where air is forcibly delivered into the lungs, and negative pressure ventilation, where air is drawn into the lungs through movement of the chest. Mechanical ventilators are commonly used in the treatment of respiratory ailments, strokes, chronic obstructive pulmonary disease, and other medical conditions. Mechanical ventilation is a life-sustaining technique that assists patients with severe illnesses in maintaining vital breathing functions.
Increase in the Geriatric Population: The growing geriatric population and the prevalence of chronic respiratory disorders are expected to drive the demand for ventilators. Increased awareness of lung cancer symptoms and a higher number of patients in medical facilities contribute to significant market growth for ventilators. However, it is important to consider that the use of mechanical ventilation may pose certain risks, such as an increased risk of infection and potential lung damage. These factors should be taken into account when assessing the market growth potential of mechanical ventilators.
Market Overview | |
---|---|
Forecast Period | 2018-2028 |
Market Size 2022 | USD 3.74 Billion |
Market Size 2028 | USD 4.98 Billion |
CAGR 2023-2028 | 4.86% |
Fastest Growing Segment | Intensive Care Unit/Critical Care |
Largest Market | North America |
Surging Prevalence of Chronic Obstructive Pulmonary Disease (COPD): The rising prevalence of COPD and other disorders, including sleep apnea, acute lung injury, and hypoxemia, are the main drivers of market growth. Additionally, the increasing number of preterm births and the rapid growth of the geriatric population are expected to further accelerate market expansion. Furthermore, the high prevalence of tobacco smoking, a leading cause of respiratory diseases, will significantly contribute to market growth. According to the World Health Organization (WHO), currently, around 90% of COPD deaths occur in low- and middle-income countries. As a result, the global market is expected to witness growth due to the increasing prevalence of such diseases, introduction of new products, and the availability of cost-effective, portable, and user-friendly mechanical ventilators for respiratory treatment. For instance, in August 2020, Spicejet introduced Spiceoxy, a portable non-invasive ventilation device. The rising awareness among end users is expected to drive demand in the forecast period.
Home healthcare, including home ventilation, can be more cost-effective compared to extended hospital stays or long-term care in medical facilities. Home care can also reduce the burden on healthcare systems by freeing up hospital beds for more critical cases. Many patients prefer receiving medical care, including ventilatory support, in the comfort of their own homes. Home healthcare offers greater autonomy, better quality of life, and reduced exposure to hospital-acquired infections. Furthermore, the advantages of home healthcare such as convenience and comfort coupled with the cost advantages are also expected to fuel market growth. Additionally, increasing healthcare infrastructure and rising disposable income will lead to high demand for home healthcare, thus acting as a significant driver for the market. Moreover, the rising awareness among the patients regarding the respiratory diseases also cushions the market's growth within the forecasted period.
Technological advancements, such as rapid innovation in the field of Positive Airway Pressure (PAP) devices, enhanced portability, and improved battery life of transport and portable devices, serve as key drivers in promoting the utilization of mechanical ventilators. In April 2020, InnAccel Technologies announced the development of a non-invasive ventilation system designed for ICU use with COVID-19 patients. This system, engineered and manufactured in India, addresses the needs of patients experiencing deteriorating hypoxemia. Furthermore, the versatility of this system allows for application across various settings and clinical scenarios, eliminating the need for continuous electricity or a trained breathing therapist. The emergence of technological advancements in ventilators, combined with the increasing number of intensive care beds (ICU), will contribute to the market's growth. Furthermore, the growing adoption of non-invasive ventilators is anticipated to drive the demand for Mechanical Ventilators. Non-invasive ventilation employs various interfaces and has continuously evolved to prioritize patient comfort and effectiveness. In recent decades, non-invasive ventilation through nasal or facemask delivery has gained recognition in supporting both chronic and acute ventilatory failure.
Operating a hospital involves substantial fixed costs, such as building maintenance, utilities, and equipment purchases. With lower patient volumes in rural areas, these fixed costs become a more significant burden on the facility's budget. Rural hospitals often have limited access to capital and financial resources compared to larger urban hospitals. They may struggle to invest in expensive medical equipment like mechanical ventilators, which can impact patient care capabilities. Budgetary constraints faced by small healthcare facilities are also expected to restrict the adoption of Mechanical Ventilators. Rural and suburban hospitals strive to provide patients with the highest quality of care while simultaneously overcoming challenges posed by their remote geographic location, limited workforce, small size, and constrained financial resources. The low patient volumes in rural hospitals make it challenging for these organizations to manage the significant fixed costs associated with hospital operations. Consequently, they become particularly susceptible to policy and market changes, as well as to Medicare and Medicaid payment reductions.
Ventilator-associated pneumonia is a common complication in patients on mechanical ventilation. It occurs when bacteria enter the lungs through the ventilator tube, leading to infection. VAP can prolong hospital stays and increase the risk of morbidity and mortality. Prolonged ventilator usage can result in ventilator dependency, where the patient becomes reliant on the machine to breathe and has difficulty weaning off the ventilator. The potential risks associated with the utilization of mechanical ventilators may impede the industry's growth. The introduction of germs through the artificial airway poses an infection risk, while the repeated opening and closing of the lungs' microscopic air sacs can lead to lung injury. As a result, the usage of these devices is expected to present challenges to the ventilators market in the forecast period.
Non-invasive ventilation carries a lower risk of complications compared to invasive mechanical ventilation. Intubation is an invasive procedure that can lead to complications such as ventilator-associated pneumonia, tracheal injury, and ventilator-induced lung injury. In some cases, NIV can be used for outpatient management of respiratory conditions, providing patients with the flexibility to receive treatment at home or in a less acute care setting. Non-invasive ventilation can be used as a bridge to wean patients off invasive mechanical ventilation. It allows for a gradual reduction in ventilator support, helping patients regain independent breathing. There is a growing interest in developing non-invasive ventilation options that provide effective respiratory support without the need for intubation. This could reduce the risk of complications associated with invasive mechanical ventilation.
Remote monitoring allows healthcare professionals to access real-time data on patients' ventilatory parameters, such as tidal volume, respiratory rate, airway pressure, and oxygen levels. This continuous data stream provides valuable insights into the patient's respiratory status, facilitating prompt decision-making. Continuous remote monitoring enables healthcare providers to detect subtle changes in the patient's condition promptly. Sudden fluctuations or trends in the data can trigger alerts, allowing for early intervention and preventing potential complications. With remote monitoring, healthcare professionals can minimize direct contact with the patient and the ventilator, reducing the risk of potential healthcare-associated infections, especially during infectious disease outbreaks. Ventilators with remote monitoring capabilities could provide continuous data streams to healthcare professionals, facilitating early intervention and better management of patients on mechanical ventilation.
Based on the product, the intensive care unit segment is anticipated to witness substantial market growth throughout the forecast period. This growth can be attributed to multiple factors, such as the clinical benefits offered by the ventilator in acute respiratory failure, compromised lung functions, or any breathing-related complications. These mechanical ventilators are extensively utilized to ensure proper ventilation and provide support in healthcare facilities. Advanced monitoring and visual decision support are among the key driving factors of these mechanical ventilators, which are expected to have a positive impact on the market share of mechanical ventilators during the forecast period.
Based on the end user segment, the hospital and clinic segment has been the dominant force in the market. The increased availability of trained healthcare providers has contributed to the effective operation and utilization of ventilators, resulting in improved productivity of hospitals and a focus on delivering quality care services to customers. These factors are key drivers of market growth and will continue to propel the market forward during the forecast period. Leading players in the industry are expanding their hospital chains to enhance diagnostic capabilities and provide effective treatment. These hospitals are also investing in infrastructure to offer a comprehensive range of services to combat respiratory diseases. These developments, along with the growing preference among customers for hospital-based treatment of chronic respiratory conditions, contribute to the growth of the healthcare facilities segment. Overall, the market is poised for growth due to the convergence of these factors and the ability of hospitals to offer advanced technologies and convenient access to healthcare services.
North America region dominated the market in 2022, primarily due to the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory ailments that necessitate non-invasive ventilation. The region benefits from a well-established healthcare infrastructure and the presence of key players like Becton, Dickinson, and Company (BD) in New Jersey, U.S., further driving market growth. Additionally, the North American region is witnessing increased intensive care admissions and the emergence of novel ventilation modes such as acute non-invasive ventilation, contributing to the expansion of the Mechanical Ventilators Market.
Furthermore, the Asia-Pacific region is projected to exhibit the highest compound annual growth rate (CAGR) during the forecast period of 2022-2028. This growth can be attributed to factors like the escalating prevalence of respiratory ailments like asthma and lung cancer in the region. Both non-invasive ventilation and invasive ventilation are among the modes of ventilation utilized. Moreover, the rising pervasiveness of coronavirus ailment is acting as a catalyst for the progress of the Mechanical Ventilators Market in the Asia-Pacific region.
In this report, the Global Mechanical Ventilators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Mechanical Ventilators Market.
Global Mechanical Ventilators market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report: